Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$854,451
New position
Shares Held
8,014
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#357
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 99%
Shared 0%
None 1%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $10,785,344 across 13 Biotechnology names. INSM ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
59,032 | $3,219,605 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
66,310 | $2,586,752 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,400 | $892,007 | |
| 4 | INSM |
INSMED Inc
This page
|
8,014 | $854,451 | |
| 5 | EXEL |
Exelixis, Inc.
|
12,313 | $669,950 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,120 | $556,337 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
9,442 | $540,271 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
4,002 | $347,973 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $854,451 | 8,014 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||